Zobrazeno 1 - 10 of 90 pro vyhledávání: '"Rob M, Kok"'
3
The impact of personality traits on the course of frailty
Autor: Elizabeth G.T. Bos, Jamila Douairi, Rob M. Kok, Isis Koolhoven, Nathaly Rius Ottenheim, Didi Rhebergen, Richard C. Oude Voshaar
Publikováno v: Bos, E G T, Douairi, J, Kok, R M, Koolhoven, I, Rius Ottenheim, N, Rhebergen, D & Oude Voshaar, R C 2023, ' The impact of personality traits on the course of frailty ', Clinical Gerontologist . https://doi.org/10.1080/07317115.2023.2165469
Clinical Gerontologist. Routledge
Objectives: Determinants of frailty are generally explored within context of somatic healthcare and/or lifestyle characteristics. To examine the impact of personality traits on change in frailty and the potential role of depression. Methods: A 2-year
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a2a269267fadb069441f58abcf8de05
https://research.vumc.nl/en/publications/f4d78ca7-09c2-4119-bc66-81531c2ad480
Zobrazit plný text záznamu
4
ECT non­remitters: prognosis and treatment after 12 unilateral electroconvulsive therapy sessions for major depression
Autor: Rob M. Kok, Esmée Verwijk, M. van Duist, Harm-Pieter Spaans
Publikováno v: Journal of Affective Disorders, 272, 501-507. Elsevier
Journal of affective disorders, 272, 501-507. Elsevier
Background: Depressive disorder causes significant suffering in patients and caregivers worldwide. Electroconvulsive therapy (ECT) is a highly effective antidepressant treatment, but little is known about the prognosis and treatment of patients who d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c86ca8a388798f64fb9683872f5f1825
https://doi.org/10.1016/j.jad.2020.03.134
Zobrazit plný text záznamu
5
Predicting rehospitalisation in older inpatients with a psychotic disorder
Autor: Julia F. van den Berg, Rob M. Kok, Nicolien Kist
Publikováno v: International Journal of Geriatric Psychiatry. 35:1151-1155
OBJECTIVE The objective of this study was to predict rehospitalisation in a psychiatric clinic in older inpatients with a psychotic disorder. METHODS/DESIGN In this prospective, observational study, all eligible inpatients aged 55 years and over with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d5660044eca153f42c8256ba400885
https://doi.org/10.1002/gps.5337
Zobrazit plný text záznamu
6
[Reducing depressive symptoms in patients with dementia]
Autor: Rob M, Kok
Publikováno v: Nederlands tijdschrift voor geneeskunde. 165
This comment is a reflection on the article 'Comparative efficacy of interventions for reducing symptoms of depression in people with dementia: systematic review and network meta-analysis' of Jennifer Watt et al. (BMJ 2021;372:n532). Although 256 RCT
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e8e2f39cfafef25c951d9c8b754bf4d9
https://pubmed.ncbi.nlm.nih.gov/34854612
Zobrazit plný text záznamu
7
Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine A Pragmatic Randomized Controlled Trial (CYSCE Trial)
Autor: Maarten J. Postma, Jaap Nanninga, Jan G Maring, Bob Wilffert, Max L. Stek, Arne J. Risselada, Liesbeth Vleugel, Eelko Hak, Elizabeth J J Berm, Richard C. Oude Voshaar, Hans Mulder, Jurjen van der Schans, Kaspar Ditters, Rob J. van Marum, Rob M. Kok, Paul A. F. Jansen, Jacobus R. B. J. Brouwers, Laura Breuning, Ron H.N. van Schaik
Publikováno v: van der Schans, J, Hak, E, Postma, M, Breuning, L, Brouwers, J R B J, Ditters, K, Jansen, P A F, Kok, R M, Maring, J G, van Marum, R, Mulder, H, Nanninga, J, Oude Voshaar, R C, Risselada, A J, Vleugel, L, Stek, M, van Schaik, R H N, Berm, E J J & Wilffert, B 2019, ' Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine : A Pragmatic Randomized Controlled Trial (CYSCE Trial) ', Journal of Clinical Psychopharmacology, vol. 39, no. 6, pp. 583-590 . https://doi.org/10.1097/JCP.0000000000001129
Journal of Clinical Psychopharmacology, 39(6), 583-590. LIPPINCOTT WILLIAMS & WILKINS
Journal of Clinical Psychopharmacology, 39(6), 583-590. Lippincott Williams & Wilkins
Journal of Clinical Psychopharmacology, 39(6), 583-590. Lippincott Williams and Wilkins
PURPOSE/BACKGROUND: The duration of untreated depression is a predictor for poor future prognosis, making rapid dose finding essential. Genetic variation of the CYP2D6 isoenzyme can influence the optimal dosage needed for individual patients. The aim
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9603589bc87ecef76b8b880c252333b
https://hdl.handle.net/1765/122247
Zobrazit plný text záznamu
8
Tolerability of lithium: A naturalistic discontinuation study in older inpatients (≥60 years)
Autor: Els Jacoba Maria van Melick, Natasja Schutter, Marinke Flapper, Rob M. Kok, Jos P. C. M. van Campen
Publikováno v: International journal of geriatric psychiatryREFERENCES. 36(8)
OBJECTIVES Lithium is one of the most effective treatment options in both bipolar disorder and treatment-resistant depression. The use of lithium in older patients declined during the last decades, probably resulting in undertreatment of older patien
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d608f39db2736e9b83f3629b61994c1
https://pubmed.ncbi.nlm.nih.gov/33644915
Zobrazit plný text záznamu
10
Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring
Autor: Eric N. van Roon, Rob M. Kok, Henricus G. Ruhé, Adrie Seldenrijk, Tom K. Birkenhäger, Cornelis Kramers, Mascha Groothedde-Kuyvenhoven, Wim Verbeeck, Roberto Bakker, Mirjam Simoons, Hans Mulder, Mirjam Westra
Publikováno v: Drug Safety, 41(7), 655-664. Adis
Drug Safety, 41(7), 655-664. Adis International Ltd
Drug Safety, 41(7), 655-664. ADIS INT LTD
Simoons, M, Seldenrijk, A, Mulder, H, Birkenhäger, T, Groothedde-Kuyvenhoven, M, Kok, R, Kramers, C, Verbeeck, W, Westra, M, van Roon, E, Bakker, R & Ruhé, H 2018, ' Limited evidence for risk factors for Proarrhythmia and sudden cardiac death in patients using antidepressants : Dutch consensus on ECG monitoring ', Drug Safety, vol. 41, no. 7, pp. 655-664 . https://doi.org/10.1007/s40264-018-0649-z
Drug Safety, 41, 655-664
Drug safety
Drug Safety, 41, 7, pp. 655-664
Contains fulltext : 193583.pdf (Publisher’s version ) (Open Access) Currently, there is a lack of international and national guidelines or consensus documents with specific recommendations for electrocardiogram (ECG) screening and monitoring during
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::435442cd25dbc8c56549799a01eac33f
https://doi.org/10.1007/s40264-018-0649-z
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje